Shoolini University Researcher Validates Pharmacological Potential Of Himalayan Plants Against Respiratory Ailments And Infections
(MENAFN- ForPressRelease)
Mumbai / Solan, 29th August 2025: Himalayan medicinal plants, traditionally used by tribal communities for generations, are being scientifically validated for their health potential in managing conditions such as asthma, fever, jaundice, body pain, respiratory issues, and infections. A major body of work by Dr. Radha, Assistant Professor and In-Charge of the Herbarium and Drug Museum at the School of Biological and Environmental Sciences, Shoolini University, has shown that many of these plants are rich in bioactive compounds with antioxidant, antimicrobial, anti-inflammatory, antidiabetic, anticancer, and hepatoprotective properties. In 2025, she has filed four patents that mark one of the first steps in transforming this indigenous knowledge into functional foods and natural antimicrobial extractions.
Among the plants studied, Bombax ceiba (Semal) flowers are especially promising. Traditionally valued for their cooling and restorative effects, they have been found to contain dietary fibre, phenols, and flavonoids that contribute to antioxidant and anti-inflammatory activities and help address dietary deficiencies. Building on this, Dr. Radha developed a nutrient-rich jam fortified with Bombax ceiba flowers and apple pulp, and a ready-to-serve drink that retains its bioactive compounds. Both formulations are entirely free from artificial preservatives and colourants. Scientific reviews also highlight the flower's potential antidiabetic, anticancer, antimicrobial, and hepatoprotective properties.
Two other Himalayan plants demonstrated strong antimicrobial action in laboratory studies. Prinsepia utilis (Himalayan Cherry), long used in traditional Indian and Chinese medicine, yielded extracts rich in phenolic acids, flavonoids, and triterpenoids. Tests showed inhibition of Klebsiella pneumoniae and Streptococcus pyogenes, including resistant strains-providing the first laboratory evidence of antimicrobial activity in this plant. Similarly, Tinospora cordifolia (Giloy), widely used in Ayurveda for immunity, was processed using an eco-friendly ultrasonic method that preserved 13 bioactive antimicrobial compounds. The extracts were effective against multi-drug-resistant bacteria, confirming its role as a natural antimicrobial agent.
Dr. Radha said,“The tribes of the Himalayas hold a living library of ecological wisdom. Many of their remedies for asthma, jaundice, fever, and infections have now been validated in the laboratory for their pharmacological potential. Our goal is to bridge this traditional knowledge with scientific evidence so that it can contribute to preventive healthcare while also protecting biodiversity.”
Beyond these findings, Dr. Radha's ethnobotanical surveys have documented over 1,600 Himalayan plant species, many of which were analyzed for their phytochemical composition and pharmacological potential. Her landmark study, A Survey on Ethnoveterinary Medicines Used by the Tribal Migratory Shepherds of Northwestern Himalaya, is the first of its kind, recording 181 plant species used by shepherds to treat livestock ailments during their migrations.
However, unsustainable harvesting-particularly of roots and barks-poses a serious threat to endemic and endangered Himalayan plants such as Picrorhiza kurroa (Kutki), Gentiana kurroo (Indian Gentian), Lilium polyphyllum (White Himalayan Lily), and Elymus himalayanus (Himalayan Wild Barley). This makes the scientific documentation and conservation of traditional knowledge increasingly critical.
Her work is supported by the Advanced National Research Foundation (ANRF) and conducted in collaboration with the Botanical Survey of India (Dehradun), Dr. Y.S. Parmar University of Horticulture and Forestry (Nauni), Shoolini University's School of Pharmaceutical Sciences, and international partners including Stanford University, East Carolina University, Clemson University, Texas Tech University, and the University of Vigo (Spain).
By highlighting the pharmacological properties of Himalayan plants and validating them through patent filings, Dr. Radha's work demonstrates how traditional remedies can inform evidence-based innovations in healthcare, while also emphasizing the urgent need for biodiversity conservation.
About Shoolini University
Shoolini University, nestled in the serene foothills of the Himalayas in Himachal Pradesh, is renowned for its research-driven approach and consistently ranks among India's top private universities. It has been recognized as India's No. 1 Private University in the Quacquarelli Symonds (QS) World University Rankings 2026 and Times Higher Education (THE) World University Rankings for 2025 and as a Top 100 NIRF University in 2024, further distinguished by its NAAC A+ accreditation.
Shoolini is home to a vibrant community of passionate researchers, diligent students and dedicated faculty. The university is deeply committed to sustainability with a 100% solar-powered campus that recycles every drop of water and implements sustainable practices to minimize its ecological footprint.
Among the plants studied, Bombax ceiba (Semal) flowers are especially promising. Traditionally valued for their cooling and restorative effects, they have been found to contain dietary fibre, phenols, and flavonoids that contribute to antioxidant and anti-inflammatory activities and help address dietary deficiencies. Building on this, Dr. Radha developed a nutrient-rich jam fortified with Bombax ceiba flowers and apple pulp, and a ready-to-serve drink that retains its bioactive compounds. Both formulations are entirely free from artificial preservatives and colourants. Scientific reviews also highlight the flower's potential antidiabetic, anticancer, antimicrobial, and hepatoprotective properties.
Two other Himalayan plants demonstrated strong antimicrobial action in laboratory studies. Prinsepia utilis (Himalayan Cherry), long used in traditional Indian and Chinese medicine, yielded extracts rich in phenolic acids, flavonoids, and triterpenoids. Tests showed inhibition of Klebsiella pneumoniae and Streptococcus pyogenes, including resistant strains-providing the first laboratory evidence of antimicrobial activity in this plant. Similarly, Tinospora cordifolia (Giloy), widely used in Ayurveda for immunity, was processed using an eco-friendly ultrasonic method that preserved 13 bioactive antimicrobial compounds. The extracts were effective against multi-drug-resistant bacteria, confirming its role as a natural antimicrobial agent.
Dr. Radha said,“The tribes of the Himalayas hold a living library of ecological wisdom. Many of their remedies for asthma, jaundice, fever, and infections have now been validated in the laboratory for their pharmacological potential. Our goal is to bridge this traditional knowledge with scientific evidence so that it can contribute to preventive healthcare while also protecting biodiversity.”
Beyond these findings, Dr. Radha's ethnobotanical surveys have documented over 1,600 Himalayan plant species, many of which were analyzed for their phytochemical composition and pharmacological potential. Her landmark study, A Survey on Ethnoveterinary Medicines Used by the Tribal Migratory Shepherds of Northwestern Himalaya, is the first of its kind, recording 181 plant species used by shepherds to treat livestock ailments during their migrations.
However, unsustainable harvesting-particularly of roots and barks-poses a serious threat to endemic and endangered Himalayan plants such as Picrorhiza kurroa (Kutki), Gentiana kurroo (Indian Gentian), Lilium polyphyllum (White Himalayan Lily), and Elymus himalayanus (Himalayan Wild Barley). This makes the scientific documentation and conservation of traditional knowledge increasingly critical.
Her work is supported by the Advanced National Research Foundation (ANRF) and conducted in collaboration with the Botanical Survey of India (Dehradun), Dr. Y.S. Parmar University of Horticulture and Forestry (Nauni), Shoolini University's School of Pharmaceutical Sciences, and international partners including Stanford University, East Carolina University, Clemson University, Texas Tech University, and the University of Vigo (Spain).
By highlighting the pharmacological properties of Himalayan plants and validating them through patent filings, Dr. Radha's work demonstrates how traditional remedies can inform evidence-based innovations in healthcare, while also emphasizing the urgent need for biodiversity conservation.
About Shoolini University
Shoolini University, nestled in the serene foothills of the Himalayas in Himachal Pradesh, is renowned for its research-driven approach and consistently ranks among India's top private universities. It has been recognized as India's No. 1 Private University in the Quacquarelli Symonds (QS) World University Rankings 2026 and Times Higher Education (THE) World University Rankings for 2025 and as a Top 100 NIRF University in 2024, further distinguished by its NAAC A+ accreditation.
Shoolini is home to a vibrant community of passionate researchers, diligent students and dedicated faculty. The university is deeply committed to sustainability with a 100% solar-powered campus that recycles every drop of water and implements sustainable practices to minimize its ecological footprint.
Company :-Dentsu Creative PR
User :- Ankush Chavan
Email :...

Legal Disclaimer:
MENAFN provides the
information “as is” without warranty of any kind. We do not accept
any responsibility or liability for the accuracy, content, images,
videos, licenses, completeness, legality, or reliability of the information
contained in this article. If you have any complaints or copyright
issues related to this article, kindly contact the provider above.
Most popular stories
Market Research

- Japan Well Intervention Market Size To Reach USD 776.0 Million By 2033 CAGR Of 4.50%
- Vietnam Artificial Intelligence Market Size, Share, Growth, Demand And Report 2025-2033
- Industrial Hose Market Size, Trends, Growth Factors, Latest Insights And Forecast 2025-2033
- Nutritional Bar Market Size To Expand At A CAGR Of 3.5% During 2025-2033
- What Does The Europe Cryptocurrency Market Report Reveal For 2025?
- North America Perms And Relaxants Market Size, Share And Growth Report 2025-2033
Comments
No comment